메뉴 건너뛰기




Volumn 39, Issue 5, 2013, Pages 498-506

Treatment of patients with small-cell lung cancer: From meta-analyses to clinical practice

Author keywords

Chemotherapy; Extensive disease; Limited disease; Maintenance therapy; Meta analysis; Radiotherapy; Randomized trial; Small cell lung cancer

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL PRODUCT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; METHOTREXATE; PLACEBO; TOPOTECAN; VINCRISTINE;

EID: 84876978699     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2012.09.006     Document Type: Review
Times cited : (39)

References (47)
  • 1
    • 33750603100 scopus 로고    scopus 로고
    • Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
    • Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
    • (2006) J Clin Oncol , vol.24 , pp. 4539-4544
    • Govindan, R.1    Page, N.2    Morgensztern, D.3
  • 2
    • 26644438582 scopus 로고    scopus 로고
    • Small-cell lung cancer
    • Jackman D.M., Johnson B.E. Small-cell lung cancer. Lancet 2005, 366:1385-1396.
    • (2005) Lancet , vol.366 , pp. 1385-1396
    • Jackman, D.M.1    Johnson, B.E.2
  • 4
    • 0027064913 scopus 로고
    • Meta-analysis: state of the science
    • Dickerson K., Berlin J.A. Meta-analysis: state of the science. Epidemiol Rev 1992, 14:154-176.
    • (1992) Epidemiol Rev , vol.14 , pp. 154-176
    • Dickerson, K.1    Berlin, J.A.2
  • 5
    • 33244455415 scopus 로고    scopus 로고
    • Traitements en oncologie thoracique: l'apport des meta-analyses
    • 8S81-9
    • Sculier J.P. Traitements en oncologie thoracique: l'apport des meta-analyses. Rev Mal Respir 2005, 22. 8S81-9.
    • (2005) Rev Mal Respir , vol.22
    • Sculier, J.P.1
  • 6
    • 5444269445 scopus 로고    scopus 로고
    • Meta-analyses based on abstracted data: a step in the right direction, but only a first step
    • Piedbois P., Buyse M. Meta-analyses based on abstracted data: a step in the right direction, but only a first step. J Clin Oncol 2004, 22:3839-3841.
    • (2004) J Clin Oncol , vol.22 , pp. 3839-3841
    • Piedbois, P.1    Buyse, M.2
  • 8
    • 84876997473 scopus 로고    scopus 로고
    • Lung cancer, oat cell (small cell). <> [accessed June 10, 2012].
    • Maghfoor I, Perry M. Lung cancer, oat cell (small cell). <> [accessed June 10, 2012]. http://emedicine.medscape.com/article/280104-overview.
    • Maghfoor, I.1    Perry, M.2
  • 9
    • 0034129381 scopus 로고    scopus 로고
    • Is there a case for cisplatin in the treatment of small-cell lung cancer A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent
    • Pujol J.L., Carestia L., Daurès J.P. Is there a case for cisplatin in the treatment of small-cell lung cancer A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 2000, 83:8-15.
    • (2000) Br J Cancer , vol.83 , pp. 8-15
    • Pujol, J.L.1    Carestia, L.2    Daurès, J.P.3
  • 11
    • 34848884868 scopus 로고    scopus 로고
    • Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines. 2nd ed
    • Simon G.R., Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines. 2nd ed. Chest 2007, 132:324S-339S.
    • (2007) Chest , vol.132
    • Simon, G.R.1    Turrisi, A.2
  • 12
    • 84876996439 scopus 로고    scopus 로고
    • National Cancer Comprehensive Center - Clinical Practice Guidelines in Oncology - Small cell Lung Cancer. Version v2.2012. <> [accessed June 10, 2012].
    • National Cancer Comprehensive Center - Clinical Practice Guidelines in Oncology - Small cell Lung Cancer. Version v2.2012. <> [accessed June 10, 2012]. http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf.
  • 13
    • 77954347979 scopus 로고    scopus 로고
    • Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
    • Sorensen M., Pijls-Joannesma M., Felip E. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl. 5):120-125.
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5 , pp. 120-125
    • Sorensen, M.1    Pijls-Joannesma, M.2    Felip, E.3
  • 14
    • 76749130508 scopus 로고    scopus 로고
    • Cisplatin versus carboplatin-based regimens in the treatment of small cell lung cancer (SCLC): meta-analysis of published randomized clinical trials (RCTs)
    • abstr D6.3
    • Rossi A., Di Maio M., Martelli O., Garassino M.C., Maione P., Gridelli C. Cisplatin versus carboplatin-based regimens in the treatment of small cell lung cancer (SCLC): meta-analysis of published randomized clinical trials (RCTs). J Thorac Oncol 2009, 4(Suppl. 1):S397-S398. abstr D6.3.
    • (2009) J Thorac Oncol , vol.4 , Issue.SUPPL. 1
    • Rossi, A.1    Di Maio, M.2    Martelli, O.3    Garassino, M.C.4    Maione, P.5    Gridelli, C.6
  • 15
    • 84863752868 scopus 로고    scopus 로고
    • Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
    • Rossi A., Di Maio M., Chiodini P., et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012, 30:1692-1698.
    • (2012) J Clin Oncol , vol.30 , pp. 1692-1698
    • Rossi, A.1    Di Maio, M.2    Chiodini, P.3
  • 16
    • 0033797356 scopus 로고    scopus 로고
    • A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
    • Mascaux C., Paesmans M., Berghmans T., et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000, 30:23-36.
    • (2000) Lung Cancer , vol.30 , pp. 23-36
    • Mascaux, C.1    Paesmans, M.2    Berghmans, T.3
  • 17
    • 35348996153 scopus 로고    scopus 로고
    • Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: a metaanalysis
    • Jiang L., Yang K.H., Mi D., et al. Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: a metaanalysis. Clin Lung Cancer 2007, 8:497-501.
    • (2007) Clin Lung Cancer , vol.8 , pp. 497-501
    • Jiang, L.1    Yang, K.H.2    Mi, D.3
  • 18
    • 77953149371 scopus 로고    scopus 로고
    • A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer
    • Jiang J., Liang X., Zhou X., et al. A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2010, 5:867-873.
    • (2010) J Thorac Oncol , vol.5 , pp. 867-873
    • Jiang, J.1    Liang, X.2    Zhou, X.3
  • 19
    • 78650513543 scopus 로고    scopus 로고
    • Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis
    • Lima J.P., dos Santos L.V., Sasse E.C., Lima C.S., Sasse A.D. Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis. J Thorac Oncol 2010, 5:1986-1993.
    • (2010) J Thorac Oncol , vol.5 , pp. 1986-1993
    • Lima, J.P.1    dos Santos, L.V.2    Sasse, E.C.3    Lima, C.S.4    Sasse, A.D.5
  • 20
    • 79551560232 scopus 로고    scopus 로고
    • Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy
    • Guo S., Liang Y., Zhou Q. Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy. J Thorac Oncol 2011, 6:406-408.
    • (2011) J Thorac Oncol , vol.6 , pp. 406-408
    • Guo, S.1    Liang, Y.2    Zhou, Q.3
  • 21
    • 84876954506 scopus 로고    scopus 로고
    • Meta-analysis of published randomized clinical trials (RCTs) comparing platinum/etoposide (PE) versus platinum/topoisomerase 1 inhibitors (PTIs) regimens for extensive-disease small-cell lung cancer (ED-SCLC)
    • abstr 447P
    • Cinquini M., Martelli O., Rossi A., Piva S., Farina G., Torri V. Meta-analysis of published randomized clinical trials (RCTs) comparing platinum/etoposide (PE) versus platinum/topoisomerase 1 inhibitors (PTIs) regimens for extensive-disease small-cell lung cancer (ED-SCLC). Ann Oncol 2010, 21(Suppl. 8):viii150. abstr 447P.
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 8 , pp. 8150
    • Cinquini, M.1    Martelli, O.2    Rossi, A.3    Piva, S.4    Farina, G.5    Torri, V.6
  • 22
    • 84858322703 scopus 로고    scopus 로고
    • An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer
    • Shao N., Jin S., Zhu W. An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2012, 7:470-472.
    • (2012) J Thorac Oncol , vol.7 , pp. 470-472
    • Shao, N.1    Jin, S.2    Zhu, W.3
  • 23
    • 0037050354 scopus 로고    scopus 로고
    • Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer
    • Noda K., Nishiwaki Y., Kawahara M., et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer. N Engl J Med 2002, 346:85-91.
    • (2002) N Engl J Med , vol.346 , pp. 85-91
    • Noda, K.1    Nishiwaki, Y.2    Kawahara, M.3
  • 24
    • 33646447066 scopus 로고    scopus 로고
    • Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
    • Hanna N., Bunn P.A., Langer C., et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006, 24:2038-2043.
    • (2006) J Clin Oncol , vol.24 , pp. 2038-2043
    • Hanna, N.1    Bunn, P.A.2    Langer, C.3
  • 25
    • 66349102227 scopus 로고    scopus 로고
    • Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
    • Lara P.N., Natale R., Crowley J., et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009, 27:2530-2535.
    • (2009) J Clin Oncol , vol.27 , pp. 2530-2535
    • Lara, P.N.1    Natale, R.2    Crowley, J.3
  • 26
    • 0026716516 scopus 로고
    • Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung A meta-analysis
    • Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung A meta-analysis. J Clin Oncol 1992, 10:890-895.
    • (1992) J Clin Oncol , vol.10 , pp. 890-895
    • Warde, P.1    Payne, D.2
  • 27
    • 0026482388 scopus 로고
    • A meta-analysis of thoracic radiotherapy for small-cell lung cancer
    • Pignon J.P., Arriagada R., Ihde D.C., et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992, 327:1618-1624.
    • (1992) N Engl J Med , vol.327 , pp. 1618-1624
    • Pignon, J.P.1    Arriagada, R.2    Ihde, D.C.3
  • 28
    • 16244389133 scopus 로고    scopus 로고
    • Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
    • Fried D.B., Morris D.E., Poole C., et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004, 22:4837-4845.
    • (2004) J Clin Oncol , vol.22 , pp. 4837-4845
    • Fried, D.B.1    Morris, D.E.2    Poole, C.3
  • 29
    • 9244240966 scopus 로고    scopus 로고
    • A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer
    • Huncharek M., McGarry R. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer. Oncologist 2004, 9:665-672.
    • (2004) Oncologist , vol.9 , pp. 665-672
    • Huncharek, M.1    McGarry, R.2
  • 30
    • 33645304581 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer
    • De Ruysscher D., Pijls-Johannesma M., Vansteenkiste J., Kester A., Rutten I., Lambin P. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 2006, 17:543-552.
    • (2006) Ann Oncol , vol.17 , pp. 543-552
    • De Ruysscher, D.1    Pijls-Johannesma, M.2    Vansteenkiste, J.3    Kester, A.4    Rutten, I.5    Lambin, P.6
  • 31
    • 33644991074 scopus 로고    scopus 로고
    • Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
    • De Ruysscher D., Pijls-Johannesma M., Bentzen S.M., et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006, 24:1057-1063.
    • (2006) J Clin Oncol , vol.24 , pp. 1057-1063
    • De Ruysscher, D.1    Pijls-Johannesma, M.2    Bentzen, S.M.3
  • 32
    • 84876969084 scopus 로고    scopus 로고
    • A meta-analysis of randomised trials using individual patient data on the timing of chest radiotherapy in patients with limited stage small cell lung cancer
    • abstr MO19.03
    • De Ruysscher D., Paris E., Le Pechoux C., et al. A meta-analysis of randomised trials using individual patient data on the timing of chest radiotherapy in patients with limited stage small cell lung cancer. J Thorac Oncol 2011, 6(Suppl. 2):S641-S642. abstr MO19.03.
    • (2011) J Thorac Oncol , vol.6 , Issue.SUPPL. 2
    • De Ruysscher, D.1    Paris, E.2    Le Pechoux, C.3
  • 33
    • 0345062339 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
    • Aupérin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999, 341:476-484.
    • (1999) N Engl J Med , vol.341 , pp. 476-484
    • Aupérin, A.1    Arriagada, R.2    Pignon, J.P.3
  • 34
    • 3042759877 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
    • Meert A.P., Paesmans M., Berghmans T., et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001, 1:5.
    • (2001) BMC Cancer , vol.1 , pp. 5
    • Meert, A.P.1    Paesmans, M.2    Berghmans, T.3
  • 35
    • 34547937885 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation in extensive small-cell lung cancer
    • EORTC Radiation Oncology Group and Lung Cancer Group
    • Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007, 357:664-672. EORTC Radiation Oncology Group and Lung Cancer Group.
    • (2007) N Engl J Med , vol.357 , pp. 664-672
    • Slotman, B.1    Faivre-Finn, C.2    Kramer, G.3
  • 36
    • 29144480913 scopus 로고    scopus 로고
    • Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC). A metaanalysis of the published controlled trials
    • Bozcuk H., Artac M., Ozdogan M., Savas B. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC). A metaanalysis of the published controlled trials. Cancer 2005, 104:2650-2657.
    • (2005) Cancer , vol.104 , pp. 2650-2657
    • Bozcuk, H.1    Artac, M.2    Ozdogan, M.3    Savas, B.4
  • 37
    • 77957020019 scopus 로고    scopus 로고
    • Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis
    • Rossi A., Garassino M.C., Cinquini M., et al. Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis. Lung Cancer 2010, 70:119-128.
    • (2010) Lung Cancer , vol.70 , pp. 119-128
    • Rossi, A.1    Garassino, M.C.2    Cinquini, M.3
  • 38
    • 67449124671 scopus 로고    scopus 로고
    • Efficacy of intensified chemotherapy with hematopoietic progenitors in small-cell lung cancer: a meta-analysis of the published literature
    • Jiang J., Shi H.Z., Deng J.M., Liang Q.L., Qin S.M., Wu C. Efficacy of intensified chemotherapy with hematopoietic progenitors in small-cell lung cancer: a meta-analysis of the published literature. Lung Cancer 2009, 65:214-218.
    • (2009) Lung Cancer , vol.65 , pp. 214-218
    • Jiang, J.1    Shi, H.Z.2    Deng, J.M.3    Liang, Q.L.4    Qin, S.M.5    Wu, C.6
  • 39
    • 0029894306 scopus 로고    scopus 로고
    • G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation
    • Messori A., Trippoli S., Tendi E. G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation. J Clin Pharm Ther 1996, 21:57-63.
    • (1996) J Clin Pharm Ther , vol.21 , pp. 57-63
    • Messori, A.1    Trippoli, S.2    Tendi, E.3
  • 40
    • 0036021711 scopus 로고    scopus 로고
    • Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis
    • Berghmans T., Paesmans M., Lafitte J.J., Mascaux C., Meert A.P., Sculier J.P. Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer 2002, 37:115-123.
    • (2002) Lung Cancer , vol.37 , pp. 115-123
    • Berghmans, T.1    Paesmans, M.2    Lafitte, J.J.3    Mascaux, C.4    Meert, A.P.5    Sculier, J.P.6
  • 41
    • 0023677771 scopus 로고
    • Teniposide in the treatment of small cell lung cancer: the influence of prior chemotherapy
    • Giaccone G., Donadio M., Bonardi G., Testori F., Calciati A. Teniposide in the treatment of small cell lung cancer: the influence of prior chemotherapy. J Clin Oncol 1988, 6:1264-1270.
    • (1988) J Clin Oncol , vol.6 , pp. 1264-1270
    • Giaccone, G.1    Donadio, M.2    Bonardi, G.3    Testori, F.4    Calciati, A.5
  • 42
    • 0031157599 scopus 로고    scopus 로고
    • Second-line chemotherapy for relapsed small cell lung cancer
    • Ebi N., Kubota K., Nishiwaki Y., et al. Second-line chemotherapy for relapsed small cell lung cancer. Jpn J Clin Oncol 1997, 27:166-169.
    • (1997) Jpn J Clin Oncol , vol.27 , pp. 166-169
    • Ebi, N.1    Kubota, K.2    Nishiwaki, Y.3
  • 44
    • 34247850949 scopus 로고    scopus 로고
    • Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline
    • Cheng S., Evans W.K., Stys-Norman D., et al. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol 2007, 2:348-354.
    • (2007) J Thorac Oncol , vol.2 , pp. 348-354
    • Cheng, S.1    Evans, W.K.2    Stys-Norman, D.3
  • 45
    • 77951461144 scopus 로고    scopus 로고
    • The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation
    • Loveman E., Jones J., Hartwell D., et al. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. Health Technol Assess 2010, 14:1-204.
    • (2010) Health Technol Assess , vol.14 , pp. 1-204
    • Loveman, E.1    Jones, J.2    Hartwell, D.3
  • 46
    • 77955532240 scopus 로고    scopus 로고
    • Systematic review of topotecan (Hycamtin) in relapsed small cell lung cancer
    • Riemsma R., Simons J.P., Bashir Z., Gooch C.L., Kleijnen J. Systematic review of topotecan (Hycamtin) in relapsed small cell lung cancer. BMC Cancer 2010, 10:436.
    • (2010) BMC Cancer , vol.10 , pp. 436
    • Riemsma, R.1    Simons, J.P.2    Bashir, Z.3    Gooch, C.L.4    Kleijnen, J.5
  • 47
    • 79151482317 scopus 로고    scopus 로고
    • Second-line chemotherapy for small-cell lung cancer (SCLC)
    • Kim Y.H., Mishima M. Second-line chemotherapy for small-cell lung cancer (SCLC). Cancer Treat Rev 2011, 37:143-150.
    • (2011) Cancer Treat Rev , vol.37 , pp. 143-150
    • Kim, Y.H.1    Mishima, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.